Skip to main content
Top

Cancer Chemotherapy and Pharmacology

Issue 6/1997

Content (13 Articles)

ORIGINAL ARTICLE

Pharmacokinetics of Adriamycin and cisplatin for anhepatic chemotherapy during liver transplantation

Y. Ku, Nobuya Kusunoki, Tetsushi Kitagawa, Ichiro Maeda, Takumi Fukumoto, Takeshi Iwasaki, Masahiro Tominaga, Yasuyuki Suzuki, Yoshikazu Kuroda, Yusuke Tanigawara, Yoichi Saitoh

ORIGINAL ARTICLE

Bromodeoxyuridine improves the cytotoxic effect of cisplatin: a comparison with 5-fluorouracil

Mohan Chelladurai, Catherine A. Lobocki, Mtanius Sultani, Yoseff Hanna, Anibal Drelichman, David R. Pieper, Patrick W. McLaughlin

ORIGINAL ARTICLE

Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer

Kaoru Kubota, Kiyoyuki Furuse, Masaaki Kawahara, Nagahisa Kodama, Mitsumasa Ogawara, Minoru Takada, Noriyuki Masuda, Shunichi Negoro, Kaoru Matsui, Nobuhide Takifuji, Shinzou Kudoh, Yoko Kusunoki, Masahiro Fukuoka

ORIGINAL ARTICLE

Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells

Carleton B. Jones, Mark K. Clements, Safia Wasi, Sayed S. Daoud

ORIGINAL ARTICLE

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma

M. Bower, E. S. Newlands, N. M. Bleehen, M. Brada, R. J. H. Begent, H. Calvert, I. Colquhoun, P. Lewis, M. H. Brampton

ORGINAL ARTICLE

Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells

Laurence M. Levasseur, William R. Greco, Youcef M. Rustum, Harry K. Slocum

ORIGINAL ARTICLE

The inactivation of doxorubicin by long ultraviolet light

Lisa Bomgaars, Sriya Gunawardena, Shannon E. Kelley, Avner Ramu

ORIGINAL ARTICLE

The effects of anesthesia on the biodistribution of drugs in rats: a carboplatin study

Alfredo R. Sancho, James A. Dowell, Walter Wolf

ORIGINAL ARTICLE

Intermittent hepatic arterial infusion of high-dose 5FU on a weekly schedule for liver metastases from colorectal cancer

Yasuaki Arai, Yoshitaka Inaba, Yoshihito Takeuchi, Yutaka Ariyoshi

SHORT COMMUNICATION

Phenytoin-induced alteration in the N-dechloroethylation of ifosfamide stereoisomers

Murray P. Ducharme, Mark L. Bernstein, Camille P. Granvil, Bärbel Gehrcke, Irving W. Wainer

SHORT COMMUNICATION

Radioenhancement by cisplatin with accelerated fractionated radiotherapy in a human tumour xenograft

Marion A. Joschko, Lorraine K. Webster, James F. Bishop, Janice Groves, Kally Yuen, Ian N. Olver, Kailash N. Narayan, David L. Ball

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine